鱼油脂肪乳对克罗恩病患者肠切除术后感染风险影响的前瞻性研究

Effects of fish oil lipid emulsion on risk of infection in patients with Crohn′s disease after enterectomy: a prospective study

  • 摘要: 目的:探讨鱼油脂肪乳对克罗恩病患者肠切除术后感染风险的影响。
    方法:
    采用前瞻性研究的方法。选取2015年6月至2017年5月南方医科大学南方医院收治的70例克罗恩病拟行肠切除术患者的临床资料。采用数字随机表法将患者分为鱼油组和对照组。由同一组手术医师行肠切除术。鱼油组患者在常规治疗措施的基础上从术后第1~5天(或更长时间)每天静脉输注100 mL 10%的鱼油脂肪乳剂(根据患者情况选择联合其他肠外营养);对照组患者术后采取常规治疗措施(根据患者情况选择静脉输注肠外营养)。观察指标:(1)两组患者术后感染情况比较。(2)两组患者术后感染风险和营养相关指标比较。(3)两组患者术后住院时间比较。正态分布的计量资料以±s表示,组间比较采用独立样本t检验,重复测量资料采用重复测量方差分析。计数资料比较采用x2检验或Fisher确切概率法,并发症发生率计算比值比(OR)值和95%可信区间。
    结果
    :筛选出符合研究条件的患者65例,其中鱼油组33例,对照组32例。(1)两组患者术后感染情况比较:18例患者发生术后感染,包括腹腔感染7例、切口感染4例、吻合口瘘4例、肺部感染2例、切口感染合并肠瘘1例。鱼油组和对照组患者术后感染发生率分别为15.2%(5/33)和40.6%(13/32),两组比较,差异有统计学意义(x2=5.265,OR=0.261,95%可信区间:0.080~0.853,P<0.05) 。(2)两组患者术后感染风险和营养相关指标比较:鱼油组术后WBC计数、中性粒细胞计数和Hb分别由术后第1天的(12.7±2.5)×109/L、(10.7±2.2)×109/L、(103±17)g/L变化为术后第5天的(9.8±4.1)×109/L、(7.5±4.1)×109/L、(101±13)g/L;对照组上述指标由术后第1天的(12.3±2.5)×109/L、(10.1±2.3)×109/L、(106±16)g/L变化为术后第5天的(11.8±5.1)×109/L、(9.6±5.1)×109/L、(100±14)g/L,两组患者上述指标变化趋势比较,差异均无统计学意义(F=1.316,0.930,0.181,P>0.05)。鱼油组术后降钙素原、C反应蛋白和Alb分别由术后第1天的(1.92±1.41)ng/mL、(30±10)mg/L、(30.0±4.1)g/L变化为术后第5天的(1.00±0.96)ng/mL、(30±27)mg/L、(34.1±4.3)g/L;对照组上述指标由术后第1天的(2.15±1.16)ng/mL、(26±7)mg/L、(31.1±3.9)g/L变化为术后第5天的(2.02±1.86)ng/mL、(58±56)mg/L、(28.5±2.6)g/L,两组上述指标变化趋势比较,差异有统计学意义(F=5.053、6.056、6.709,P>0.05)。(3)两组患者术后住院时间比较:鱼油组和对照组术后住院时间分别为(9±4)d和(12±6)d,平均缩短了3 d,两组比较,差异有统计学意义(t=-2.443,P<0.05)。
    结论:静脉输注鱼油脂肪乳可降低克罗恩病患者肠切除术后的感染风险,改善患者术后的营养状况并缩短术后住院时间。

     

    Abstract: Objective To explore the effects of fish oil lipid emulsion on risk of infection in patients with Crohn′s disease (CD) after enterectomy.
    Methods: The prospective study was conducted. The clinical data of 70 patients with CD who planned to receive enterectomy in the Nanfang Hospital of South Medical University between June 2015 and May 2017 were collected. All the patients were allocated into the fish oil group and control group by random number table method, and then underwent enterectomy by the same doctors′ team. Patients in the fish oil group received daily intravenous infusion of 100ml 10% fish oil lipid emulsion from day 1 to 5 postoperatively or longer) based on conventional treatment [combined other parenteral nutrition (PN) were selected according to patients′ conditions]; patients in the control group received conventional treatment (intravenous infusion of PN were selected according to patients′ conditions). Observation indicators: (1) postoperative infection situations between groups; (2) risk of postoperative infection and nutrition-related indexes between groups; (3) comparison of duration of postoperative hospital stay between groups. Measurement data with normal distribution were represented as ±s. The comparisons between groups were evaluated with the independent-sample t test and repeated measures data were analyzed by the repeated measures ANOVA. The comparisons of count data were analyzed using the chi-square test or Fisher exact probability. Odds ratio and 95% confidence interval (CI) for incidence of complications were calculated.
    Results
     Sixty-five patients were screened for eligibility, including 33 in the fish oil group and 32 in the control group. (1) Postoperative infection situations between groups: 18 patients in the 2 groups were complicated with postoperative infection. Abdominal infection, wound infection, anastomotic fistula, pulmonary infection and wound infection combined with intestinal fistula were detected in 7, 4, 4, 2 and 1 patients, respectively. Incidence of postoperative infection in the fish oil group and control group were respectively 15.2%(5/33) and 40.6%(13/32), with a statistically significant difference between groups (x2=5.265, OR=0.261, 95%CI: 0.080-0.853, P<0.05). (2) Risk of postoperative infection and nutrition-related indexes between groups: numbers of white blood cell (WBC) and centriole cell and level of hemoglobin (Hb) from day 1 to 5 post-operatively were respectively from (12.7±2.5)×109/L, (10.7±2.2)×109/L, (103±17)g/L to (9.8±4.1)×109/L, (7.5±4.1)×109/L, (101±13)g/L in the fish oil group and from (12.3±2.5)×109/L, (10.1±2.3)×109/L, (106±16)g/L to (11.8±5.1)×109/L, (9.6±5.1)×109/L, (100±14)g/L in the control group, showing no statistically significant difference in changing trend of above indexes between groups (F=1.316, 0.930, 0.181, P>0.05). The levels of procalcitonin, C-reactive protein and albumin (Alb) from day 1 to 5 post-operatively were respectively from (1.92±1.41)ng/mL, (30±10)mg/L, (30.0±4.1)g/L to (1.00±0.96)ng/mL, (30±27)mg/L, (34.1±4.3)g/L in the fish oil group and from (2.15±1.16)ng/mL, (26±7)mg/L, (31.1±3.9)g/L to (2.02±1.86)ng/mL, (58±56)mg/L, (28.5±2.6)g/L in the control group, showing statistically significant differences in changing trend of above indexes between groups (F=5.053, 6.056, 6.709, P>0.05). (3) Comparison of duration of postoperative hospital stay between groups: duration of postoperative hospital stay in the fish oil group and control group were respectively (9±4)days and (12±6)days, with an average shortened time of 3 days, showing a statistically significant difference between groups (t=-2.443, P<0.05).
    Conclusion Intravenous infusion of fish oil lipid emulsion could reduce risk of postoperative infection in patients with CD after enterectomy, and also improve postoperatively patients′ nutritional status and shorten duration of hospital stay.

     

/

返回文章
返回